Dimethylformamide → HCID 59681813, compound
Reaction equation
[NH2:1][C:2]1[C:3]([C:7]2(C3C=CC(NCCN(C)C)=CC=3)[NH:15][C:10]3[CH:11]=[N:12][CH:13]=[CH:14][C:9]=3[NH:8]2)=[N:4][O:5][N:6]=1.[H-].[Na+].Cl.C[N:32]([CH3:36])[CH2:33][CH2:34]Cl.[CH3:37][N:38]([CH:40]=O)[CH3:39]>>[NH2:1][C:2]1[C:3]([C:7]2[N:8]([C:9]3[CH:10]=[CH:11][C:33]([NH:32][CH2:36][CH2:40][N:38]([CH3:39])[CH3:37])=[CH:34][CH:14]=3)[C:9]3[CH:14]=[CH:13][N:12]=[CH:11][C:10]=3[N:15]=2)=[N:4][O:5][N:6]=1Participants
5
Conditions
- Temperature
- 60 °C
Procedure
To a solution containing 500 mg the product from Step 1 (1.7 mmol) in 10 mL DMF was added 200 mg of NaH (60% dispension in oil, 5.1 mmol). After 2 hours at room temperature, 246 mg of 2-(dimethylamino)ethyl chloride hydrochloride (1.7 mmol) was added, and the reaction mixture was heated to 60° C. for 5 hours. The solvent was evaporated in vacuo to yield a residue which was partitioned between ethyl acetate and brine. The organic phase was dried over anhydrous sodium sulphate, filtered, and concentrated in vacuo. Purification of the residue by Gilson reverse-phase HPLC afforded the title compound (24 mg, 4%). MS (ES+) m/e 365 [M+H]+.
Workup
- customThe solvent was evaporated in vacuo
- customto yield a residue which
- customwas partitioned between ethyl acetate and brine
- dry with materialThe organic phase was dried over anhydrous sodium sulphate
- filtrationfiltered
- concentrationconcentrated in vacuo
- customPurification of the residue by Gilson reverse-phase HPLC
Sources & evidence
- ORD record
- ord-0ed5b5476ae54a32a89347e8a107386d
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07348339B2
Reaction notes
Loading…